Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions

Phase 2 Terminated 11 enrolled Arbor Center for Eye Care

RandomizedSequentialSingle-blindTreatment

Summary

To evaluate the safety and effectiveness of the PXL Platinum 330 device for performing Corneal Crosslinking in patients with corneal thinning conditions.

Timeline

Start: 2020-07-08
Primary completion: 2023-02-18
Completion: 2023-02-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Riboflavin	Other / unclassified	—	—

Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions

Summary

Timeline

Drugs

Indications